the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Affin launches Affingem Financing Scheme to empower women entrepreneurs

KUALA LUMPUR: Affin Group today launched Affingem Financing Scheme, an initiative to help women entrepreneurs and businesses controlled by women to grow and manage their companies as they scale up.

Affin Bank Bhd said it supports underserved segments, particularly women entrepreneurs, as part of its environmental, social and governance initiatives.

Affingem is designed for working capital and capital expenditure purposes with collateral-free financing up to RM1 million, affordable financing with profit rates as low as base lending rate and base financing rate plus 0.5%, coverage of ancillary costs such as guarantee fees, legal fees and stamp duty, additional financing up to 5% of the approved financing limit for insurance and takaful. This financing scheme is also available for businesses as young as six months.

Affin Bank president and CEO Datuk Wan Razly Abdullah said, “Affin has always been a steadfast supporter of the SME community. Through this initiative, we aim to empower women in achieving their business goals and drive economic growth by providing essential tools and resources. This aligns with our vision of becoming the most creative and innovative financial company in Malaysia.”

Meanwhile, the bank hosted Affin BizChat, a flagship interactive business talk supporting entrepreneurship, delving into market trends, offering valuable business tips. The theme of “Empowering Women in Business,” was focused on igniting women’s entrepreneurial spirit and supporting women-led ventures.

Affingem was launched by Deputy Minister in the Sarawak Premier’s Department, Datuk Sharifah Hasidah Sayeed Aman Ghazali.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings